Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Analytical Tool - Prostate Cancer -' returned 109 results - Page 1 of 6  FEATURED RESULTS Cancer Diagnostic Testing World Markets Drug Delivery in Cancer - Technologies, Markets and Companies Antibody Drug Target Atlas in Oncology Antibody drug conjugates for cancer treatment: Clinical Tria... Targeting Protein Kinases for Cancer Therapy   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Analytical Tool - Prostate Cancer   Bioseeker, Feb 2011 "Analytical Tool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development. It is at the same A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market   Bioseeker, June 2010, Pages: 838 6.6 The Drug-Target Interactome 6.7 Protein Expression Levels of Identified Targets of Prostate Cancer Drugs 6.8 Pathway Assessment of Prostate Cancer Therapeutic Targets 6.8.1 Tools for Analysis Triple Analysis: Lung Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, July 2011, Pages: 2820 : A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Prostate Cancer The prostate cancer report part comprises defined and up to date development strategies for 346 prostate Triple Analysis: Breast Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, Oct 2010, Pages: 2410 strategies, and assesses them in prostate cancer. This part is based on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development Triple Analysis: Colorectal Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, March 2011, Pages: 2553 : A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Prostate Cancer The prostate cancer report part comprises defined and up to date Triple Analysis: Pancreatic Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, Oct 2010, Pages: 2107 into 187 drug target strategies, and assesses them in prostate cancer. This part is based on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Triple Analysis: Breast Cancer, Lung Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 3074 and and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part III: Prostate Cancer Triple Analysis: Colorectal Cancer, Lung Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 3217 and and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part III: Prostate Cancer Triple Analysis: Lung Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 2771 publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market The report is written for you to understand and assess the impact of competitor entry Triple Analysis: Breast Cancer, Colorectal Cancer and Prostate Cancer   Bioseeker, March 2011, Pages: 2807 on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market The report is written for you to understand and assess the impact Triple Analysis: Breast Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, May 2010, Pages: 2361 on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market The report is written for you to understand and assess the impact Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, March 2011, Pages: 2504 is based on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market The report is written for you to understand and assess Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3441 on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market Part II: Cancer Vaccines The cancer vaccine report part comprises defined Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors   Bioseeker, Oct 2010, Pages: 2939 202 identified targets of prostate cancer drugs, organized into 187 drug target strategies, and assesses them in prostate cancer. This part is based on the following publication: A Decision Support Tool Triple Analysis: Prostate Cancer, Cancer Vaccines and Peptides   Bioseeker, Nov 2011, Pages: 2403 on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market Part II: Cancer Vaccines The cancer vaccine report part comprises defined Triple Analysis: Prostate Cancer, Apoptosis and Cancer Vaccines   Bioseeker, Dec 2011, Pages: 3114 identified targets of prostate cancer drugs, organized into 187 drug target strategies, and assesses them in prostate cancer. This part is based on the following publication: A Decision Support Tool Triple Analysis: Prostate Cancer, Angiogenesis and Cancer Vaccines   Bioseeker, Jan 2012, Pages: 3201 identified targets of prostate cancer drugs, organized into 187 drug target strategies, and assesses them in prostate cancer. This part is based on the following publication: A Decision Support Tool Triple Analysis: Lung Cancer, Prostate Cancer and Protein Kinase Inhibitors   Bioseeker, July 2011, Pages: 3603 : Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Prostate Cancer The prostate cancer report part comprises defined and up to date development strategies Triple Analysis: Lung Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 4105 : A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Prostate Cancer The prostate cancer report part comprises defined and up to date development strategies for 346 prostate Triple Analysis: Lung Cancer, Prostate Cancer and Apoptosis   Bioseeker, Dec 2011, Pages: 3778 : A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Prostate Cancer The prostate cancer report part comprises defined and up to date development strategies for 346 prostate Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network